Analyst targets are being lowered amid new entrants challenging market dominance for medical technology companies.
1 report, 1 independent
Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst targets are being lowered amid new entrants challenging market dominance for medical technology companies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Intuitive Surgical
American corporation
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
TD Cowen
American investment bank
Related events
- TD Cowen raised its price target on Exelixis shares on August 30, 2026.
- TD Cowen provided analyst ratings and price targets for Ardelyx, accompanied by required stock transaction filings with the SEC.
- Analyst firms dropped price objectives and insider trading disclosures were filed with the SEC.
- Analyst firm TD Cowen provided ratings and price targets for Moog, while MarketBeat aggregated consensus data. A pension fund also bought a new stake in the company.
- Analyst rating cuts and target price increases are affecting market sentiment for Tenaris, involving Morgan Stanley and TD Cowen.